Insider Transactions in Q2 2025 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 22
2025
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
31,866
-3.91%
|
$0
$0.78 P/Share
|
|
Apr 22
2025
|
Gregory D Davis Head of Research & Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
6,708
-3.1%
|
$0
$0.78 P/Share
|
|
Apr 22
2025
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
31,866
-3.82%
|
$0
$0.78 P/Share
|
|
Apr 22
2025
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
126,950
-5.18%
|
$0
$0.78 P/Share
|
|
Apr 22
2025
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
31,866
-3.93%
|
$0
$0.78 P/Share
|